Evidence map›Paper›PMID 38198946›Full record

ReviewJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association2024

The glymphatic system and cerebral small vessel disease.

Phillip S Ang, Douglas M Zhang, Saara-Anne Azizi, Salvador A Norton de Matos, James R Brorson

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Roles of Microglia in Cerebral Small Vessel Disease.CNS neuroscience & therapeutics · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Systemic Piezo1 activation improves cerebrovascular function in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Phillip S AngUniversity of Chicago Pritzker School of Medicine, Chicago, IL 60637, United States.
Douglas M ZhangUniversity of Chicago Pritzker School of Medicine, Chicago, IL 60637, United States.
Saara-Anne AziziUniversity of Chicago Pritzker School of Medicine, Chicago, IL 60637, United States.
Salvador A Norton de MatosUniversity of Chicago Pritzker School of Medicine, Chicago, IL 60637, United States.
James R BrorsonUniversity of Chicago Pritzker School of Medicine, Chicago, IL 60637, United States; Department of Neurology, The University of Chicago, Chicago, IL 60637, United States. Electronic address: jbrorson@bsd.uchicago.edu.
University of Chicago · US

Funding

Medical Scientist National Research Service AwardT32GM150375 · NIGMS · UNIVERSITY OF CHICAGO · PI Raghavendra G Mirmira · 2023 to 2026
$5.5M
Kinetic analysis of acute stroke secondary prevention trials: Insights from combined datasets guiding future trial designR61NS135583 · NINDS · UNIVERSITY OF CHICAGO · PI BRORSON, JAMES R. · 2024 to 2025
$762k
NIGMS NIH HHS T32 GM150375NINDS NIH HHS R61 NS135583
6 · The paper itself

Abstract

objectivesCerebral small vessel disease is a group of pathologies in which alterations of the brain's blood vessels contribute to stroke and neurocognitive changes. Recently, a neurotoxic waste clearance system composed of perivascular spaces abutting the brain's blood vessels, termed the glymphatic system, has been identified as a key player in brain homeostasis. Given that small vessel disease and the glymphatic system share anatomical structures, this review aims to reexamine small vessel disease in the context of the glymphatic system and highlight novel aspects of small vessel disease physiology. MATERIALS AND

methodsThis review was conducted with an emphasis on studies that examined aspects of small vessel disease and on works characterizing the glymphatic system. We searched PubMed for relevant articles using the following keywords: glymphatics, cerebral small vessel disease, arterial pulsatility, hypertension, blood-brain barrier, endothelial dysfunction, stroke, diabetes.

resultsCerebral small vessel disease and glymphatic dysfunction are anatomically connected and significant risk factors are shared between the two. These include hypertension, type 2 diabetes, advanced age, poor sleep, obesity, and neuroinflammation. There is clear evidence that CSVD hinders the effective functioning of glymphatic system.

conclusionThese shared risk factors, as well as the model of cerebral amyloid angiopathy pathogenesis, hint at the possibility that glymphatic dysfunction could independently contribute to the pathogenesis of cerebral small vessel disease. However, the current evidence supports a model of cascading dysfunction, wherein concurrent small vessel and glymphatic injury hinder glymphatic-mediated recovery and promote the progression of subclinical to clinical disease.

Indexed as

Cerebral Small Vessel DiseasesDiabetes Mellitus, Type 2Glymphatic SystemHypertensionStrokeBrainHumansCerebrospinal fluidDementiaGlymphaticPerivascular spaceSmall vessel diseaseStroke

Identifiers

PMID38198946
PMCPMC11579894
OpenAlexW4390731436

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.